Overview
Product name | Recombinant Human TNFRSF13C/BAFFR/CD268 Protein |
---|
Catalog No. | RP01223 |
---|
Description | Recombinant Human TNFRSF13C/BAFFR/CD268 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Ser7-Ala71) of human BAFFR/TNFRSF13C (Accession #NP_443177.1) fused with a Fc, 6×His tag at the C-terminus. |
---|
Bio-Activity | Measured by its binding ability in a functional ELISA. Immobilized Human TNFSF13B at 2 μg/mL (100 μL/well) can bind Human TNFRSF13C with a linear range of 4-198 ng/mL.
|
---|
Purity | > 87% by SDS-PAGE. |
---|
Endotoxin | < 0.1 EU/μg of the protein by LAL method. |
---|
Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation. |
---|
Species | Human |
---|
Calculated MW | 33.33 kDa |
---|
Product information
Synonym | TNFRSF13C; BAFF-R; BAFFR; BROMIX; CD268; CVID4; prolixin |
---|
Expression Host | HEK293 cells |
---|
Tag | C-hFc&His |
---|
Swiss-Prot | |
---|
Gene ID | |
---|
Usage guide
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|
Reconstitution | Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.